Similar Items: Neuroprotection trial design in progressive supranuclear palsy: challenges and solutions
- Person‐centered intervention response in primary progressive aphasia: A secondary analysis of the Communication Bridge‐2 randomized clinical trial
- CSF Biomarkers of Alzheimer’s Disease: Impact on Disease Concept, Diagnosis, and Clinical Trial Design
- Simulation of long‐term lecanemab treatment effect on Alzheimer's disease progression
- Obstacles and solutions for implementing amyloid‐targeting treatments in Europe
- The utility of a composite endpoint for tracking disease progression in Lewy body dementia
- Redefining the norms: an interdisciplinary perspective on language testing in multilinguals with acquired and progressive neurogenic disorders